Question 1

What is the catalog number for N- (4-Ethoxy-phenyl) -2- (3-oxo-1,2,3,4-tetrahydro-quinoxalin-2-yl) -acetamide?

Accepted Answer

The catalog number for N- (4-Ethoxy-phenyl) -2- (3-oxo-1,2,3,4-tetrahydro-quinoxalin-2-yl) -acetamide is sc-279575.

Question 2

What sizes are available for N- (4-Ethoxy-phenyl) -2- (3-oxo-1,2,3,4-tetrahydro-quinoxalin-2-yl) -acetamide?

Accepted Answer

N- (4-Ethoxy-phenyl) -2- (3-oxo-1,2,3,4-tetrahydro-quinoxalin-2-yl) -acetamide is available in the following size(s): 1 g.

Question 3

Is N- (4-Ethoxy-phenyl) -2- (3-oxo-1,2,3,4-tetrahydro-quinoxalin-2-yl) -acetamide in stock?

Accepted Answer

N- (4-Ethoxy-phenyl) -2- (3-oxo-1,2,3,4-tetrahydro-quinoxalin-2-yl) -acetamide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the molecular weight of the target protein?

Accepted Answer

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

Question 5

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 6

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

N- (4-Ethoxy-phenyl) -2- (3-oxo-1,2,3,4-tetrahydro-quinoxalin-2-yl) -acetamide

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

CD14 (Monocyte / Macrophage Marker) (LPSR/2385), CF594 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), CF740 conjugate, 0.1mg/mL

Carboxypeptidase A1 / CPA1 (Pancreatic Cancer Marker) (CPA1/2711), CF640R conjugate, 0.1mg/mL

MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), 1mg/mL

Calcineurin A / PPP3CA (CALNA/2353), CF405S conjugate, 0.1mg/mL

MyoD1 (Rhabdomyosarcoma Marker) (MYOD1/2075R), CF647 conjugate, 0.1mg/mL